CLINICAL_TRIALS
trial_result
· 2018-03-29
Clinical Trial Update: Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 [Phase 2]
Summary
This document summarizes a Phase 2 clinical efficacy trial of mexiletine for myotonic dystrophy type 1. Results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Myotonic Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2018-03-29